SCHEMBL3075869

SCHEMBL3075869

O=C(Nc1c[nH]c(=O)c2c1CCCC2)c1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.53
▸ ALDH1A1 P00352 7/20 0.51
▸ MAPT P10636 3/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ AAK1 Q2M2I8 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ HDAC3 O15379 1/20 0.49
▸ HDAC1 Q13547 1/20 0.49
▸ HDAC2 Q92769 1/20 0.49
▸ POLB P06746 1/20 0.48
▸ PIM1 P11309 1/20 0.48
▸ PIM3 Q86V86 1/20 0.48
▸ PIM2 Q9P1W9 1/20 0.48
▸ LMNA P02545 2/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7548968 0.74 AAK1 (0.62) ALDH1A1MAPTAAK1MEN1KMT2A
SCHEMBL14836896 0.74 PARP1 (0.48) PARP1ALDH1A1MEN1KMT2A
SCHEMBL4555559 0.73 L3MBTL1 (0.70) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL10062836 0.73 ITK (0.80) AAK1FLT3HDAC3HDAC1HDAC2
SCHEMBL7053845 0.73 AAK1 (0.70) ALDH1A1MAPTAAK1HDAC3HDAC1
SCHEMBL918853 0.72 PARP1 (0.62) PARP1NPC1RAB9AMEN1KMT2A
SCHEMBL27796214 0.72 PARP1 (0.49) PARP1ALDH1A1ROCK2ROCK1
SCHEMBL28268352 0.69 AAK1 (0.56) ALDH1A1MAPTAAK1HDAC3HDAC1
SCHEMBL23565700 0.69 ROCK2 (0.62) ALDH1A1MAPTNPC1RAB9AKDM4E
SCHEMBL2330387 0.69 ALDH1A1 (0.73) ALDH1A1MAPTRAB9AKDM4EHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795278-B2 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereof SANOFI-AVENTIS DEUTSCHLAND GMBH (US) 2010-09-14 — — US disclosed
US-20070142430-A1 SUBSTITUTED TETRAHYDRO-2H-ISOQUINOLIN-1-ONE DERIVATIVES, AND METHODS FOR THE PRODUCTION AND USE THEREOF SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142430-A1 SUBSTITUTED TETRAHYDRO-2H-ISOQUINOLIN-1-ONE DERIVATIVES, AND METHODS FOR THE PRODUCTION AND USE THEREOF PARP1, PARP2, PARP11 PARP1 1/4885ALDH1A1 234/4885MAPT 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback